Founded with a mission to enhance patient convenience and medication adherence, Wilmington Pharmaceuticals develops and licenses innovative fast-dissolve drug formulations. Their core vision is to revolutionize drug delivery systems, making medication administration simpler and more effective. The company focuses on creating formulations that dissolve quickly, catering primarily to patients in the United States who require easier dosing options.

Wilmington Pharmaceuticals has garnered attention for its cutting-edge delivery technologies, which have significantly impacted patient care. While specific notable affiliated people and investors are not publicly detailed, the company's achievements in formulation development have positioned it as a key player in the pharmaceutical industry. Their advancements contribute to improved patient outcomes and set new standards in drug administration.